Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to ANTI-PSYCHOTICS


Schizophrenia: A Promising Treatment Era Dawns (CME)

Psychiatry October 10th 2023

The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia

Geriatrics October 3rd 2023

The Epoch Times

An Antipsychotic Drug Gets FDA Green Light Despite Fourfold Higher Risk of Death

Geriatrics October 3rd 2023

Annals of Internal Medicine

Comparative Safety Analysis of Oral Antipsychotics for In-Hospital Adverse Clinical Events in Older Adults After Major Surgery

Hospitalist September 12th 2023

Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Psychiatry September 6th 2023

British Medical Journal

How the FDA Approved an Antipsychotic that Failed to Show a Meaningful Benefit but Raised the Risk of Death

Geriatrics August 22nd 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form